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ABSTRACT	Apathy	is	a	prominent	symptom	of	Amyotrophic	lateral	sclerosis	(ALS),	but	measurement	is	confounded	by	physical	disability.	Furthermore	it	has	been	traditionally	measured	as	a	unidimensional	symptom	despite	research	demonstrating	a	multifaceted	construct.	The	new	Dimensional	Apathy	Scale	(DAS)	has	been	specifically	designed	for	patients	with	motor	disability	to	measure	three	neurologically	based	subtypes	of	apathy;	Executive,	Emotional	and	Initiation.	We	aimed	to	explore	this	behavioural	symptom	by	examining	the	substructure	of	apathy	in	ALS	and	to	determine	the	reliability	and	validity	of	the	DAS	in	patients	and	their	carers.		Method:	Patients	and	carers	were	recruited	through	the	national	Scottish	Motor	Neurone	Disease	Register	and	were	asked	to	complete	the	DAS,	the	standardised	Apathy	Evaluation	Scale,	and	the	Geriatric	Depression	Scale-	Short	form.	83	ALS	patients,	75	carers	and	83	sex-age-education	matched	controls	participated.	Results:	When	compared	to	healthy	controls,	patients	showed	a	significant	increase	in	apathy	on	the	Initiation	subscale,	and	were	significantly	less	apathetic	on	the	Emotional	subscale.	Scores	on	the	DAS	patient	and	carer	versions	did	not	significantly	differ.	Internal	consistency	reliability,	convergent	and	discriminant	validity	were	found	to	be	good	for	the	DAS	subscales.	There	was	no	association	between	the	DAS	and	functional	disability	using	the	ALS	Functional	Rating	Scale.	Conclusion:	Apathy	in	ALS	is	characterised	by	a	specific	profile	of	increased	Initiation	apathy	and	reduced	Emotional	apathy.	The	DAS	is	a	reliable	and	valid	measure	for	the	assessment	of	multidimensional	apathy	in	ALS.		
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INTRODUCTION	Apathy	is	defined	by	decreased	motivation	towards	goal	directed	behaviours,[1]	and	occurs	as	a	symptom	of	a	variety	of	different	psychiatric	and	neurodegenerative	diseases,[2,	3].	Studies	have	shown	that	apathy	occurs	in	30%	to	60%	of	ALS	patients	and	is	the	most	prominent	behavioural	symptom	of	the	disease,[4-7].	This	behavioural	change	in	ALS	has	most	commonly	been	detected	by	the	Frontal	Systems	Behavior	Scale	(FrSBe)	apathy	subscale,[8].	However,	this	tool	is	not	specifically	designed	to	assess	patient	populations	with	physical	disability	and	may	exaggerate	behavioural	symptoms	as	responses	to	some	items	are	reliant	on	effective	motor	functions,[9].	Other	tools	which	have	been	used	to	detect	behavioural	change	in	ALS	are	the	Cambridge	Behaviour	Inventory-	Revised,[10],	the	ALS-	Frontotemporal	Dementia-	Questionnaire,[11]	and,	finally,	the	Motor	Neurone	Disease	Behavioural	Instrument,[12].	These	measure	apathy	as	a	part	of	just	one	of	many	behavioural	or	psychiatric	disturbances	and	lack	a	detailed	analysis	of	symptoms.		Marin	originally	defined	apathy	as	a	multidimensional	concept	that	is	composed	of	factors	relating	to	cognitive,	behavioural	and	emotional	domains,[13,	14].	Although	no	previous	scales	have	been	comprehensively	designed	to	directly	measure	the	subdomains	of	apathy,	factorial	analysis	of	current	scales	has	revealed	a	sub	structure	similar	to	that	of	Marin’s	original	conceptualisation	in	Parkinson’s	disease,[15],	observing	a	traditional	triadic	substructure.	Additionally,	in	a	comparison	of	Alzheimer’s	disease	and	Frontotemporal	dementia,	apathy	was	found	to	have	differing	profile	characteristics,[16].	Specifically,	the	Neuropsychiatric	Inventory	–	apathy	subscale	items	showed	that	
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behavioural	variant	Frontotemporal	dementia	patients	were	reported	as	more	frequently	showing	lack	of	initiation,	decreased	emotional	output	and	diminished	interest	towards	friends	or	family,	when	compared	to	Alzheimer’s	disease	patients.	However,	no	such	research	has	been	undertaken	in	ALS	as	yet.		Traditional	instruments	measure	apathy	as	a	unidimensional	symptom	despite	clear	evidence	of	a	multidimensional	substructure.	The	new	Dimensional	Apathy	Scale	(DAS),[17]	was	designed	in	a	cohort	of	healthy	adults	for	use	in	neurodegenerative	disease	patient	populations	with	motor	symptoms.	The	DAS	was	specifically	designed	to	measure	three	neurobehavioral	apathy	subtypes,[18,	19]	through	theory	based	analysis	and	selection	of	items.	It	assesses	apathetic	impairments	associated	with	planning,	attention	or	organization	(Executive),	emotion	integration	(Emotional)	and	self-generation	of	behaviours	or	cognition	(Initiation).	The	DAS	has	been	shown	to	have	good	internal	consistency	reliability,	with	subscales	having	a	moderate	relationship	to	depression	and	is	the	only	method	that	comprehensively	measures	apathy	subtypes.		Apathy	and	depression	have	been	reported	to	have	a	variable	relationship,	with	some	studies	describing	them	as	distinct	factors	and	others	reporting	an	association.[20,	21].	Lack	of	interest,	insight	and	reduced	energy	have	been	suggested	as	overlapping	characteristics	of	apathy	and	depression,	with	dysphoria,	suicidal	ideation	and	helplessness	being	depression	specific	and	indifference,	diminished	initiation	and	poor	persistence	being	apathy	specific,[22-25].	Documenting	the	relationship	between	apathy	and	depression	
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in	neurodegenerative	disease	remains	important	as	they	may	be	differentially	affected	or	overlapping	symptoms	misattributed.			The	aim	of	this	study	was	to	determine	why	apathy	is	a	particularly	prominent	feature	of	ALS	through	an	exploration	of	the	substructure	of	this	behavioural	symptom.	In	addition	we	aimed	to	determine	the	psychometric	properties	of	the	DAS,	namely	the	validity	as	assessed	against	a	standardised	measure	of	apathy	and	its	association	with	depression	and	disease	related	disability.			
METHOD	
Procedure	and	Participants	El	Escorial	criteria	diagnosed	ALS	patients	and	their	carers	were	recruited	from	the	national	Scottish	Motor	Neurone	Disease	Register.	Patients	were	recruited	via	postal	survey.	Patients	with	Primary	lateral	sclerosis	or	Progressive	muscular	atrophy	were	not	included	in	the	study.	Carers	were	recruited	via	the	patients	through	a	chain-referral	sampling	method.	Patients	were	anonymously	pre-screened	for	severe	disability	as	a	result	of	disease	progression	that	would	hinder	completion	of	the	survey,	pre-existing	dementia,	severe	diabetes,	epilepsy,	alcohol/substance-	related	disorders,	severe	head	injury	(that	required	intensive	care	setting	hospitalisation),	traumatic	brain	injury	(inclusive	of	subarachnoid	haemorrhage)	and	any	other	significant	medical	illness	(such	as	stroke).			Of	190	ALS	patients	who	were	contacted,	46.8%	patients	and	44.2%	carers	returned	the	postal	survey.	Of	the	participants	who	returned	the	survey,	3.5%	of	
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patients	and	5.9%	of	carers	returned	incomplete	questionnaires	and	were	subsequently	excluded.	A	further	3.5%	of	carers	did	not	have	a	matched	patient	completed	form	and	were	also	excluded.	This	resulted	in	83	ALS	patients	and	75	carers	being	included	in	the	study.		400	healthy	control	participants	completed	the	study.	They	were	recruited	via	web-based	survey	and	were	mostly	from	the	University	of	Edinburgh	Psychology	Departmental	Volunteer	Panel.	Before	recruitment,	they	were	additionally	pre-screened	for	any	serious	physical	or	mental	health	issues.	83	healthy	controls	were	subsampled	from	this	pool	to	match	the	patient	group	for	sex	distribution,	age	and	years	of	education.		Ethical	approval	was	obtained	from	the	National	Health	Service	(NHS)	South	East	Scotland	Research	Ethics	Committee	02	and	the	School	Philosophy,	Psychology	and	Language	Sciences	(PPLS)	Ethical	Committee.		
Apathy	The	DAS,[17]	is	multidimensional	scale	composed	of	24	items	constituting	3	subscales	assessing	Executive,	Emotive	and	Initiation	apathy.	Items	were	scored	using	a	4-point	Likert	scale	based	on	the	frequency	of	occurrence	in	the	last	month.	The	minimum	score	for	each	subscale	is	0	(least	apathy)	and	the	maximum	24	(most	apathy),	with	a	total	score	of	72.	It	was	shown	to	have	good	internal	consistency	reliability	and	to	have	a	weak	to	moderate	relationship	with	depression.	A	self	version	has	been	previously	reported	by	the	authors	and	a	
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carer	version	was	adapted	specifically	for	this	study1.	Normative	data	was	subsequently	used	to	suggest	abnormality	level	cut-offs	for	each	subscale	based	on	≥2	SD	above	the	mean	(see	Table	1).		
Table	1.	Normative	Data	on	DAS	(N=83)		 Mean	(SD)	 Range	 Abnormality	cut-off		DAS	Executive	subscale	 5.9	(4.2)	 0–17	 14	DAS	Emotional	subscale	 8.8	(2.9)	 3–19	 15	DAS	Initiation	subscale	 9.5	(3.5)	 1–17	 16	DAS	Total		 24.1	(7.3)	 8-42	 39	
DAS=Dimensional	Apathy	Scale,	the	maximum	for	each	subscale	is	24	and	the	total	is	72		The	Apathy	Evaluation	Scale	(AES),[14]	is	composed	of	18	items	and	is	scored	on	a	4	point	Likert	scale	based	on	frequency	of	occurrence	in	the	last	month.	It	produces	one	composite	score,	where	the	minimum	score	is	18	(least	apathy)	and	maximum	score	of	72	(most	apathy).	The	recommended	cut-offs	for	the	self	version	is	based	on	2	standard	deviations	above	the	mean,[14].	For	our	control	sample	this	was	39,	which	is	consistent	with	the	original	study.	The	carer	version	cut-off	was	defined	as	40.	The	AES	is	a	well-established	method	of	detecting	apathy,	and	has	been	shown	to	be	both	valid	and	reliable,[3,	25].	Both	a	carer	and	patient	versions	were	available.			
Depression	Geriatric	Depression	Scale-Short	form	(GDS-15),[26,	27]	is	an	abridged	version	of	the	Geriatric	Depression	Scale.	It	is	composed	of	15	items,	with	statements	
																																																								1	See	Supplementary	material	
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graded	on	a	dichotomous,	yes-no	scale	within	the	previous	week.	The	minimum	score	is	0	(not	depressed)	with	the	maximum	being	15	(most	depressed).	Recommended	cut-offs	for	the	patient	self	rated	version	are	disputed	but	highest	consensus	in	the	literature	is	a	cut-off	of	>6	for	presence	of	depressive	symptoms,[28].	Both	a	patient	and	carer	version	were	used.		
Disease	Related	Disability		The	ALS	Functional	Rating	Scale-Revised	(ALSFRS-R),[29]	is	a	12	domain	global	functioning	and	disability	measure	specifically	designed	for	assessment	of	ALS	patients.	Each	domain	scored	on	a	5	point	scale	with	the	total	score	ranges	from	0	(maximum	disability)	and	48	(normal	motor	function).		
Statistical	Analysis	R	and	SPSS	statistics	19.0	was	used	to	analyse	the	results.	Independent	t-tests	and	Chi-square	tests	were	used	to	compare	demographics,	symptom	frequency	and	clinical	variables	between	ALS	patients,	and	controls,	DAS	Subscale	impaired	patients	and	unimpaired	patients.	Internal	consistency	reliability	was	assessed	using	Cronbach’s	Standardized	alpha.	Validity	was	examined	using	correlational	analysis	(Holm	corrected	Pearson’s	r).	A	2	x	3	Mixed	design	Analysis	of	variance	(ANOVA)	was	used	for	comparison	of	Group	(Patients	vs	Carers/Controls)	and	DAS	subscale	(Emotional	vs	Executive	vs	Initiation).	Post	hoc	Independent	t-tests	were	used	for	subscale	and	factor	comparison.	
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RESULTS	
Table	2.	Demographic	and	descriptive	data	for	ALS	patients	(N=83),	their	
carers	(N=75)	and	controls	(N=83)		 ALS	Patient	 ALS	Carer	 Control	 Patient	vs	Control	p-value	DAS	Total	Score	(mean,	SD)	 25.7	(10.6)	 27.3	(12.8)	 24.1	(7.3)	 n.s.	DAS	Total	(Apathy/No	Apathy)	 12/71	 14/61	 2/81	 <.01	AES	Score	(mean,	SD)	 30.9	(8.6)	 32.8	(10.9)	 28.9	(5.0)	 n.s.	AES	(Apathy/No	Apathy)	 20/63	 18/57	 1/82	 <.001	GDS-15	Score	(mean,	SD)	 5.9	(4.2)	 6.7	(4.7)	 2.5	(2.8)	 <.001	Age	(mean,	SD)	 64.6	(10.5)	 	 63.7	(13.0)	 n.s.	Years	of	Education	(mean,	SD)	 13.5	(3.4)	 	 14.4	(2.7)	 n.s.	ALSFRS-R	Score	(mean,	SD)	†	 37.7	(6.2)	 	 	 	Age	of	onset	(mean,	SD)	years†	 59.6	(11.0)	 	 	 	Disease	duration	(Median,	IQR)	months††	 66.5	(71)	 	 	 	
ALS=Amyotrophic	lateral	sclerosis;	SD=standard	deviation;	DAS=Dimensional	Apathy	
Scale;	AES=Apathy	Evaluation	Scale;	GDS-15=Geriatric	depression	scale-	Short	form;		
ALSFRS-R=ALS	Functional	Rating	Scale-Revised;	n.s.=not	significant;	IQR=Interquartile	
range	
†	N=32	
††	N=62	 	Background	Information	There	was	no	significant	difference	between	patients	and	controls	on	age	and	years	of	education	(see	Table	2).	Sex	distributions	were	matched,	with	57	males	and	26	female	participants	in	both	samples.	The	most	common	carer	relationship	to	the	ALS	patient	was	a	spouse.			
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	Apathy	(AES)	and	Depression	The	results	of	the	AES	revealed	that	the	total	score	was	not	found	to	significantly	differ	between	patients	and	controls,	however	the	number	of	individuals	who	fell	above	the	suggested	cut-off	for	abnormality	did,	with	significantly	increased	levels	of	abnormal	apathy	in	the	patient	group	(see	Table	2).			In	this	sample,	according	to	the	AES,	24%	of	patients	self	rated	and	24%	of	carers	rated	patients	as	apathetic.	Depression	rates	were	higher,	with	patient-rated	depression	at	39%	and	carer-rated	depression	at	44%.	Additionally,	patient	reported	depression	scores	were	found	to	be	significantly	different	when	compared	to	controls	and	just	under	borderline	diagnosis	level	(see	Table	2).	Furthermore	the	AES	was	found	to	be	positively	correlated	with	GDS-15	in	patients	(r(73)	=	.65,	p	<	.001)	and	carers	(r(81)	=	.67,	p	<	.001).	
	
Patient	(self-rated)	and	Carer-rated	comparison	on	the	DAS	
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The	comparison	between	Group	(Self	vs	Carer)	and	DAS	subscales	is	presented	in	Figure	1.	There	was	no	significant	interaction	between	Group	and	the	DAS	Subscales	with	carer’s	ratings	being	only,	on	average	0.7,	points	higher	than	patient	self	ratings.	However,	there	was	a	significant	main	effect	relating	to	DAS	subscales		(F(2,296)	=	160.30,	p	<	.001).	Post	hoc	independent	t-tests	within	groups	showed	that	in	patients	the	DAS	Executive	subscale	differed	significantly	from	Emotional	subscale	(t(164)	=	3.53,	p	<	.01)	and	the	Initiation	subscales	(t(164)	=	9.11,	p	<	.001),	in	addition	there	was	a	significant	difference	between	Emotional	and	Initiation	subscales		(t(164)	=	7.19,	p	<	.001).	In	carers,	a	similar	relationship	between	subscales	was	found	where	the	DAS	Executive	and	Emotional	subscales	differed	significantly	(t(148)	=	3.42,	p	<	.01),	along	with	Executive	and	Initiation	subscales	(t(148)	=	7.93,	p	<	.001)	and	Emotional	and	Initiation	subscales	(t(148)	=	5.45,	p	<	.001).	There	was	no	significant	difference	on	the	DAS	total	score	between	patient	and	carer	ratings.												
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Patient	(self-rated)	and	Healthy	Control	comparison	on	the	DAS	
		A	comparison	of	group	(Self	vs	Control)	and	DAS	Subscale,	showed	a	significant	main	effect	for	DAS	subscales	(F(2,328)	=	107.16,	p	<	.001)	indicating	dissociations	between	subscales	(see	Figure	2).	In	addition,	a	significant	interaction	was	also	found	between	Group	and	DAS	subscales,	reflecting	differential	performance	between	patients	and	controls	on	the	different	subscales	(F(2,328)	=	18.56,	p	<	.001).			Further	post	hoc	t-tests	showed	that	Initiation	was	the	only	subscale	in	which	patients	were	significantly	more	apathetic	than	controls	(t(164)	=	4.52,	p	<	.001).		Additionally,	on	the	emotional	apathy	subscale,	patients	scored	significantly	lower	when	compared	to	control	participants	(t(164)	=	2.15,	p	<	.05).	The	DAS	total	score	did	not	significantly	differ	between	patients	and	controls.		
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Psychometrics	The	overall	DAS	Cronbach’s	Standardized	alpha	values	were	0.86	for	the	self-version	and	0.90	for	carer-version,	which	can	be	interpreted	as	good	and	excellent	[3],	respectively.	There	were	good	internal	consistencies	for	both	the	Executive	(self	=	0.86,	carer	=	0.88)	and	Initiation	(self	=	0.83,	carer	=	0.86)	subscales,	with	the	poorest	being	for	self	DAS	Emotional	subscale	at	0.43.	However,	the	carer	Emotional	subscale	showed	a	higher	internal	consistency	at	0.65.		
Table	3.	Patient	(self	rated)	and	carer	rated	DAS	subscale	correlations	
compared	to	standardised,	self-report	apathy	(AES)	and	depression	
(GDS15)	measures		Self	(N=83)	 AES	 GDS-15	DAS	Executive	subscale	 0.76***	 0.61***	DAS	Emotional	subscale	 0.21	 0.20	DAS	Initiation	subscale	 0.79***	 0.61***	DAS	Total	 0.80***	 0.67***	Carer	(N=75)	 AES	 GDS-15	DAS	Executive	subscale	 0.82***	 0.64***	DAS	Emotional	subscale	 0.44***	 0.24*	DAS	Initiation	subscale	 0.79***	 0.65***	DAS	Total	 0.85***	 0.64***	
DAS=Dimensional	Apathy	Scale;	AES=Apathy	Evaluation	Scale;	GDS-15=Geriatric	
Depression	Scale-	Short	Form		 	 	 	 	 	 				p<.001***,	p<.05*		The	DAS	Subscales	positively	correlated	with	the	AES,	with	moderate	correlations	with	the	Emotional	subscale	and	strong	correlations	with	the	Executive	and	Initiation	subscales	(see	Table	3).	Similarly	the	carer	DAS	subscales	were	more	positively	correlated	with	the	AES	compared	to	the	GDS-15.		
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Disease	related	disability	A	total	of	32	patient’s	and,	of	those,	27	carer’s	ALSFRS-R	scores	were	acquired.	The	ALSFRS-R	did	not	significantly	correlate	with	the	self	DAS	Executive	subscale,	Emotional	subscale,	Initiation	subscale	and	the	total	score.	When	compared	to	the	carer	version	of	the	DAS,	the	ALSFRS-R	was	also	not	significantly	correlated	with	any	of	the	subscales	and	the	total	score.			
Diagnostic	cut-off	for	the	DAS	Using	the	abnormality	level	cut-offs	in	Table	1,	28%	of	ALS	patients	were	impaired	on	at	least	one	apathy	subscale,	of	which	61%	were	impaired	on	the	Initiation	subscale	only	and	39%	were	impaired	on	Initiation	and	one	other	subscale	(30%	Executive	and	9%	Emotional).	In	carers,	43%	were	impaired	in	at	least	one	subscale,	where	56%	were	impaired	on	the	Initiation	subscale	only,	10%	on	the	Executive	subscale	only	and	6%	on	the	Emotional	subscale	only.	A	further	16%	displayed	Initiation	and	Executive	apathy	with	6%	showing	Initiation	and	Emotional	apathy.	A	total	of	6%	showed	apathy	on	all	3	subscales.		
Table	4.	Comparison	of	patients	(carer-rated)	impaired	on	≥1	DAS	
Subscales	(N=25)	to	patients	unimpaired	on	all	subscales	(N=34)		 ≥1	Subscale	Impairment	 Unimpaired	 p-value	ALSFRS-R	(Mean,	SD)	 38.8	(4.2)	†	 36.6	(8.8)	††	 n.s.	Disease	duration	(Median,	IQR)	 45	(53)	 98	(74)	 <.05	Age	of	Onset	(Mean,	SD)	 57.2	(11.4)	 60.6	(10.6)	 n.s.	Site	of	Onset	(%)	 	 	 		 Bulbar	(N=15)	 26.7%	 73.3%	 		 Lower	Limb	(N=21)	 47.6%	 52.4%	 	
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	 Upper	Limb	(N=19)	 47.4%	 52.6%	 		 Mixed	(N=4)	 50%	 50%	 	
ALSFRS-R=ALS	Functional	Rating	Scale-	Revised;	SD=standard	deviation;	n.s.=not	
significant;	IQR=Interquartile	range	
†	N=10	
††	N=11		Table	4.	is	a	comparison	clinical	variables	in	apathetic	and	non-apathetic	patients	as	defined	by	impairment	on	at	least	one	DAS	subscale	as	rated	by	the	carer.	Of	the	75	carer	rated	DAS	scores,	16	patient’s	clinical	variables	were	unavailable,	resulting	in	a	total	of	59	patient’s	clinical	variables	being	used.	There	was	a	significant	difference	between	the	two	groups	on	disease	duration,	wherein	≥1	Subscale	Impairment	patients	had	the	disease	for	a	shorter	time	at	assessment.	The	proportion	of	impaired	and	unimpaired	patients	with	lower	limb,	upper	limb	and	mixed	onset	was	relatively	equal,	although	those	with	bulbar	onset	were	more	likely	to	be	unimpaired	than	impaired.	However,	frequency	distributions	did	not	differ	using	Chi-square	statistics	(which	excluded	the	mixed	onset	in	the	analysis).	 	
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		Figure	3	shows	a	further	subdivision	of	impairment	(impaired	on	all	three	subscales,	impaired	on	two	subscale	and	impaired	on	one	subscale)	based	on	site	of	onset.	All	bulbar	onset	patients	who	were	impaired	on	the	DAS	showed	impairment	on	one	subscale,	while	those	with	lower	limb	onset	and	upper	limb	onset	were	impaired	on	2	or	more	subscales.	The	only	2	instances	of	global	impairment	were	in	the	upper	limb	onset	group.	The	most	common	impairment	on	one	subscale	across	all	groups	was	on	the	Initiation	subscale.		
DISCUSSION	The	DAS	was	shown	to	be	sensitive	to	apathy	in	ALS,	where	28%	of	patients	and	43%	of	carers	in	our	sample	showed	abnormal	levels	of	apathy	on	at	least	one	
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subscale.	The	prevalence	of	apathy	reported	here	is	slightly	lower	than	previous	studies,	where	apathy	was	reported	between	30-60%	of	the	patients	sampled	[4-7].	However	previous	studies	have	utilised	measures,	which	have	not	been	designed	for	physical	disability	and	where	symptoms	of	apathy	may	be	exaggerated	by	motor	dysfunction.	The	more	conservative	estimate	reported	here	might	be	therefore	a	more	accurate	reflection	given	that	the	DAS	was	designed	to	measure	apathy	independent	of	physical	disability.			The	most	prevalent	DAS	subscale	impairment	was	in	Initiation	with	ALS	patients	showing	significantly	increased	Initiation	apathy	compared	to	controls.	Initiation	apathy	consists	of	a	lack	of	self	generated	behaviour	and	cognition,[22].	Such	processes	are	also	dependent	on	intact	executive	functions,	which	are	known	to	be	affected	in	ALS,[30].		Stuss	proposed	a	model	of	executive	functions	that	includes	the	concept	of	energization,	defined	as	diminished	initiation	and	sustainment	of	responses	to	tasks,[31,	32]	and	which	clearly	has	overlap	with	Initiation	apathy.	Energization	deficits	are	often	observed	as	decreased	output	during	verbal	fluency	tasks,	increased	errors	and	slow	response	time	for	Stroop	tasks.	This	verbal	fluency	deficit	is	a	characteristic	feature	of	the	cognitive	profile	in	ALS,[30]	and	has	been	found	to	correlate	with	apathy	as	measured	by	the	FrSBe,[4].	Further	research	using	the	Edinburgh	Cognitive	and	Behavioural	ALS	Screen	(ECAS),[33]	found	a	high	prevalence	of	the	fluency	deficit	in	ALS	patients	and,	additionally,	reported	apathy	as	the	most	prevalent	behavioural	impairment	although	the	behaviour	screen	contains	just	one	item	on	apathy.	
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	Initiation	apathy	is	akin	to	one	of	Levy	and	Dubois	apathy	subtypes-	Auto	Activation,[18].	This	type	of	apathy	has	been	related	to	lesions	in	the	medial	prefrontal	region,	anterior	cingulate	cortex	and	caudate	nucleus.	Brain	imaging	studies	have	found	abnormalities	in	ALS	patients	in	the	anterior	cingulate	cortex	to	be	related	to	apathy,[34]	and	the	caudate	nucleus	has	also	been	shown	to	be	affected	in	ALS,	and	it	was	posited	that	this	may	be	involved	with	the	mediation	of	motivation,[35].	Similarly	verbal	fluency	deficits	(the	key	feature	of	the	energization	deficit)	has	been	related	to	dysfunction	of	similar	prefrontal	regions,[36,	37].		It	is	of	note	that	the	Executive	subscale	showed	no	difference	between	patients	and	controls.	This	subscale	assesses	apathy	as	a	result	of	poor	planning,	organisation	and	attention.	At	first	glance	this	appears	inconsistent	with	research	demonstrating	executive	dysfunction	is	a	common	feature	in	non-demented	ALS	patients	as	revealed	through	neuropsychological	evaluation.	However	there	are	very	few	reports	of	this	deficit	manifesting	behaviourally	or	having	an	impact	on	daily	functioning	in	non-demented	ALS	patients,[38,	39].	Current	research	within	ALS	distinguishes	between	the	types	of	executive	functions,	which	are	impaired	with	distinct	neural	substrates,[37].	The	distinction	between	Initiation	and	Executive	apathy	is	further	supported	by	Levy	and	Dubois,[18,	19],	and	our	own	data	driven	approach,	which	also	separated	these	two	factors,[17]	in	healthy	controls.	The	findings	here	demonstrate	that	the	processes	of	initiation	of	thought	and	action	appear	to	be	the	crucial	element,	which	underlie	the	behavioural	manifestation	of	apathy	in	ALS.		
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	The	finding	of	lower	Emotional	apathy	in	ALS,	when	compared	to	controls,	may	be	related	to	dysfunction	in	emotional	processing,	theory	of	mind	and	social	cognition	in	ALS	which	has	been	recently	documented,[9].	A	deficit	in	social	cognition	has	been	associated	with	apathy,	although	cognitive	impairment	was	associated	with	an	increased	level	of	apathy,[7].	Future	studies	may	demonstrate	whether	this	social	cognitive	impairment	is	related	to	increased	Initiation	apathy	specifically.	Other	factors	must	be	considered	in	relation	to	this	lack	of	emotional	indifference	in	ALS	patients.	These	may	include	increased	sensitivity	to	emotion	associated	with	reaction	and	impact	of	having	a	terminal	disease.	However	it	should	be	noted	that	there	was	only	a	weak	correlation	between	emotional	apathy	and	depression,	which	was	in	a	positive	direction,	i.e.	the	more	apathetic	the	more	depressive	symptoms.	Conversely	the	patients	with	lower	emotional	apathy	tended	towards	fewer	depressive	symptoms.	However	ALS	patients	do	show	a	higher	incidence	of	emotional	lability,	which	is	involuntary	occurrence	of	positive	(laughing)	and	negative	(crying)	emotions,[40],	which	may	be	regarded	as	the	antithesis	of	Emotional	apathy.	Emotional	lability	was	not	recorded	here	and	it	may	serve	as	an	underlying	factor	in	the	reduced	emotional	apathy	in	ALS	patients.		There	were	some	differences	in	clinical	variables	between	patients	with	apathy	and	those	without	when	broken	down	by	the	impairment	on	the	DAS.	Patients	with	apathy	as	defined	by	impairment	on	one	or	more	subscales	had	the	disease	for	a	shorter	number	of	months	when	compared	to	unimpaired	patients.	This	is	consistent	with	the	finding	that	apathy	is	the	most	common	behavioural	change	
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associated	with	the	onset	of	disease,	as	measured	by	the	FrSBe,[4].	It	would	also	be	of	interest	to	explore	how	apathy	develops	through	progression	of	the	disease.	Cognitive	impairment	has	been	shown	to	be	a	negative	prognostic	factor,[41]	and	the	current	research	poses	the	question	of	whether	this	is	also	true	of	patients	with	apathy.	Prospective	studies	may	also	determine	the	course	of	this	symptom	and	whether	apathy	characterises	a	distinct	subgroup	of	patients.		Further	break	down	of	impairment	showed	that	all	patients	irrespective	of	site	of	onset	were	most	commonly	impaired	on	one	subscale,	that	being	Initiation.	This	provides	further	evidence	that	the	Initiation	deficit	is	that	which	defines	apathy	in	ALS.	It	is	also	of	interest	that	the	patients	with	bulbar	onset	did	not	show	a	greater	vulnerability	to	apathy,	and	therefore	does	not	support	previous	associations	of	cognitive	and	behaviour	change	and	bulbar	symptomology,[42].		Given	that	functional	disability	data	was	only	available	on	a	subgroup	of	patients,	although	no	correlations	emerged	here,	the	relationship	between	this	behavioural	symptom	and	physical	dysfunction	and	progression	should	be	further	explored.		The	DAS	was	found	to	be	a	psychometrically	robust	instrument	for	detecting	apathy	in	ALS,	with	very	little	difference	between	patient	and	carer	ratings.	There	was	a	consistent	dissociation	between	the	DAS	subscales	in	patients,	carers	and	also	controls,	providing	evidence	for	the	DAS	measuring	distinct	subtypes	of	apathy.	Previous	reviews	of	assessment	methods	in	ALS	outlined	one	of	the	main	issues	of	behavioural	measurement	is	that	it	is	confounded	by	motor	
		
	 21	
dysfunction,[9].	The	DAS	was	specifically	designed	to	account	for	these	motor	symptoms	and	the	current	findings	of	apathy	were	independent	of	functional	disability	supporting	its	usage	in	patients	with	motor	symptoms.	Furthermore,	our	control	samples	apathy	levels,	as	measured	by	the	AES,	were	comparable	to	that	of	Marin’s	in	his	original	validation	of	the	AES	(Mean=28.1,	Standard	Deviation=6.4),[14]	making	our	control	group	no	more	apathetic	than	in	Marin’s	original	study	and	therefore	suitable	for	comparison	to	the	patients	group.		The	internal	consistency	reliability	for	the	whole	DAS	was	good,	with	it	being	higher	for	the	carer	(0.90)	than	the	self	version	(0.86).	When	examining	subscale	internal	consistency	reliability,	we	found	that	the	self	and	carer	Executive	and	Initiation	subscales	were	found	to	be	very	reliable	however,	the	self	DAS	Emotional	subscale	was	found	to	be	poor.	Patients’	self	awareness	may	be	affecting	performance	on	the	self	rated	questionnaire,	and	there	is	some	evidence	of	poor	insight	in	ALS	patients,[43].	However	it	is	at	present	unclear	why	this	would	differentially	affect	the	emotional	component	and	this	interaction	may	be	an	area	for	future	research.	The	internal	consistency	for	the	carer	Emotional	subscale	was	markedly	higher,	suggesting	that	the	carer	assessment	might	be	a	more	informative	method	of	assessing	Emotional	apathy.			Our	study	found	that	associations	with	the	DAS	apathy	subscales	and	the	standardized	apathy	measure	(AES)	were	on	average	more	positive	and	stronger	than	with	the	depression	measure	(GDS-15),	resulting	in	a	good	convergent	and	discriminant	validity	of	the	DAS.	When	looking	specifically	at	the	Emotional	apathy	subscale,	the	self	version	was	marginally	more	positively	associated	with	
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the	AES	than	the	GDS-15,	however	the	difference	was	minor.	The	carer	DAS	Emotional	subscale	more	positively	and	strongly	associated	with	the	AES	than	the	GDS-15,	showing	in	a	good	validity	and	reliability	of	this	subscale.	The	prevalence	of	depression	in	our	patient	sample	was	found	to	be	in	line	with	that	of	other	studies,[44].			A	caveat	of	all	apathy	research	is	volunteerism,	where	participants	who	participate	in	studies	are	likely	to	be	more	motivated	and	less	apathetic.	Our	study	may,	therefore,	be	underrepresenting	the	prevalence	of	apathy	in	ALS.		However	the	response	rate	of	the	current	research	(46.8%	patients	and	44.2%	carers)	is	as	good	if	not	better	than	other	MND	studies,[6].			To	conclude,	the	DAS	is	a	psychometrically	valid	and	reliable	instrument	for	detecting	dissociable	apathy	subtypes,	independent	of	physical	disability.	Apathy	in	ALS	seems	to	be	defined	by	specific	impairments	in	initiation	of	cognition	and	behaviour.	Additionally,	patients	seem	to	exhibit	a	lack	of	Emotional	apathy.	These	novel	findings	suggest	that	apathy	in	ALS	has	a	specific	profile	relating	to	initiation	and	emotion.	The	relationship	between	these	subtypes	and	cognitive,	behavioural	and	emotional	change	should	be	further	explored.	Furthermore	the	DAS	is	appropriate	to	use	to	determine	different	apathetic	profile	impairments	in	other	neurodegenerative	diseases,	in	which	apathy	is	most	prevalent.	Future	research	should	look	to	investigate	the	neuropsychological	correlates	associated	with	different	apathetic	subscale	profiles	in	addition	to	quality	of	life	and	both	patient	and	caregiver	burden	with	the	aim	of	directing	care.			
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